Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05606302

A Multi-center Clinical Study of Drug Antibody and Precision Transfusion in China

Conditions: Drug-specific Antibodies

Sex: All
Enrollment: 14000
Sponsor: Nanfang Hospital of Southern Medical University

Location: China

Summary

Blood samples for hemolytic anemia in patients treated with one or more of the antibiotics including piperacillin, amoxicillin, cefazolin, cefuroxime, ceftriaxone, cefoxitin sodium, and vancomycin were screened for the production of drug antibodies.

Eligibility Criteria

Inclusion Criteria:Voluntary signing of informed consent;No limitation on age or sex;No limitation on nationality;Regional unlimited;Participates treated with one or more of the drugs including piperacillin, amoxicillin, cefazolin, cefuroxime, ceftriaxone, cefoxitin sodium, and vancomycin.Exclusion Criteria:High fat blood sample;Sample of severe hemolysis;Jaundice sample;The sample is cloudy and may be contaminated with bacteria;The source of the sample is unknown and cannot be traced;Patients with a history of medication who were deemed inappropriate to participate in this study were evaluated by the researchers.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05606302). StuddyBuddy aggregates publicly available trial information.